We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RL icon
2201
Ralph Lauren
RL
$23.1B
$1.08M ﹤0.01%
7,837
+4,546
+138% +$606K
TCBK icon
2202
TriCo Bancshares
TCBK
$1.85B
$1.08M ﹤0.01%
+27,881
New +$1.08M
ATRA icon
2203
Atara Biotherapeutics
ATRA
$78.1M
$1.08M ﹤0.01%
1,041
-15
-1% -$14.7K
PFI icon
2204
Invesco Dorsey Wright Financial Momentum ETF
PFI
$60.1M
$1.08M ﹤0.01%
31,533
-45,793
-59% -$1.61M
CUTR
2205
DELISTED
Cutera, Inc.
CUTR
$1.08M ﹤0.01%
33,050
+2,150
+7% +$78.3K
EDIT icon
2206
Editas Medicine
EDIT
$438M
$1.07M ﹤0.01%
33,778
+1,505
+5% +$48.6K
NSP icon
2207
Insperity
NSP
$2.04B
$1.07M ﹤0.01%
9,099
-2,197
-19% -$239K
LVHD icon
2208
Franklin US Low Volatility High Dividend Index ETF
LVHD
$629M
$1.07M ﹤0.01%
35,018
-692
-2% -$21.3K
KL
2209
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$1.07M ﹤0.01%
56,314
+7,991
+17% +$163K
BSCI
2210
DELISTED
Invesco BulletShares 2018 Corporate Bond ETF
BSCI
$1.07M ﹤0.01%
50,528
+3,505
+7% +$74.1K
UDR icon
2211
UDR
UDR
$12.1B
$1.07M ﹤0.01%
26,405
+1,086
+4% +$42.3K
IHF icon
2212
iShares US Healthcare Providers ETF
IHF
$1.26B
$1.07M ﹤0.01%
26,690
+7,610
+40% +$289K
IGLB icon
2213
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.8B
$1.06M ﹤0.01%
18,274
+9,130
+100% +$534K
CAE icon
2214
CAE Inc. Common Shares
CAE
$8.5B
$1.06M ﹤0.01%
52,376
+2,069
+4% +$42.3K
EMLC icon
2215
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$1.06M ﹤0.01%
32,299
+10,106
+46% +$337K
XT icon
2216
iShares Future Exponential Technologies ETF
XT
$4.01B
$1.06M ﹤0.01%
27,465
+4,358
+19% +$166K
ALKS icon
2217
Alkermes
ALKS
$8.31B
$1.06M ﹤0.01%
25,031
+314
+1% +$13.6K
GHDX
2218
DELISTED
Genomic Health, Inc.
GHDX
$1.06M ﹤0.01%
15,120
+158
+1% +$9.24K
AERI
2219
DELISTED
Aerie Pharmaceuticals
AERI
$1.06M ﹤0.01%
17,175
-8,399
-33% -$540K
CDTX
2220
DELISTED
Cidara Therapeutics
CDTX
$1.05M ﹤0.01%
11,990
+2,196
+22% +$194K
ESS icon
2221
Essex Property Trust
ESS
$18.5B
$1.05M ﹤0.01%
4,275
+1,884
+79% +$454K
LDP icon
2222
Cohen & Steers Duration Preferred & Income Fund
LDP
$601M
$1.05M ﹤0.01%
44,124
+6,146
+16% +$152K
SHG icon
2223
Shinhan Financial Group
SHG
$35.2B
$1.05M ﹤0.01%
26,199
+139
+0.5% +$5.37K
VIV icon
2224
Telefônica Brasil
VIV
$18.1B
$1.05M ﹤0.01%
107,951
-6,161
-5% -$65.1K
BOH icon
2225
Bank of Hawaii
BOH
$3.15B
$1.05M ﹤0.01%
13,289
+162
+1% +$13.4K

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.